Cancer Management & Treatment | Cancer Research & Drug Trials

Top News

Mirvetuximab Soravtansine Deemed New Standard Care in FRα+ Platinum-Resistant Ovarian Cancer

Toripalimab Improves PFS in PD-L1+ Recurrent/Metastatic TNBC

Add-On Prostate Radiotherapy for De Novo Low-Volume mCSPC Improves Outcomes

RIST Improves PFS in Relapsed/Refractory Neuroblastoma

Chemotherapy Shortage Affecting More Than 90% of NCCN Cancer Centers Surveyed

Cancer Vaccine mRNA-4157 Improves RFS, DMFS in High-Risk Melanoma

Sacituzumab Govitecan Improves OS and PFS in HR+, HER2- Metastatic Breast Cancer

Nivolumab Plus AVD Could Be New Standard Care in Classic Hodgkin Lymphoma

Chinese Company May Help Ease US Shortage of Cisplatin

Immune Checkpoint Inhibitor Rechallenge of No Benefit in Advanced RCC

Trastuzumab Deruxtecan Shows Activity in HER2+ Metastatic Colorectal Cancer

Erdafitinib Bests Chemotherapy in FGFR-Altered Metastatic Urothelial Carcinoma

EDITORIAL ADVISORY BOARD

Barbara Ann Burtness, MD

Steven Cohen, MD

E. David Crawford, MD

Don S. Dizon, MD, FACP

Jeffrey M. Farma, MD

Neal D. Shore, MD, FACS

Mark A. Socinski, MD

Mario Sznol, MD

Click here for complete profiles

Featured

ASCO 2023

News from the ASCO Annual Meeting 2023
Update on Bladder Cancer Risk Factors

A recent review provided an update on traditional and novel risk factors for bladder cancer that may help guide prevention efforts.
State of Cancer Research: Impact of COVID-19, Brexit, War, and Other Global Events

In the last few years, cancer research has been hindered by the COVID-19 pandemic, Brexit, the war in Ukraine, and tensions between world superpowers.
Global Survey Suggests RCC Patients Are Underinformed, Face Obstacles to Care

Results of a global survey highlight areas for improvement in the care of patients with renal cell carcinoma.
Lack of Access to Abortion Has Had a Negative Impact on Cancer Care

Since the US Supreme Court overturned Roe v Wade last year, restrictions on access to abortion have had a negative impact on cancer care.

More Features

Lung cancer

AACR 2023 Highlights Novel Research in NSCLC and ES-SCLC

By

Tori Rodriguez, MA, LPC, AHC

Ibrutinib No Longer Approved for MCL, MZL: How This Change Will Affect Patients

By

Mary Ellen Schneider

Could Shopping Data Be Used to Predict Cancer and Diagnose It Earlier?

By

Carina Storrs, PhD

Could mRNA Vaccines Help Prevent Recurrence in Pancreatic Cancer?

By

Alan P. Lyss, MD

ART and Pediatric Cancer: Risk May Vary by Method Used, Cancer Type

By

Carina Storrs, PhD

More Features »

Fact Sheets

Vaccination

Fact Sheet: COVID-19 Vaccine Considerations for Patients With Cancer

COVID-19 testing

What to Expect: Enrolling on a Cancer Clinical Trial During COVID-19